Related Experiment Video
Updated: Jun 7, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Targeted antimicrobial regimens for Gram-negative prosthetic joint infections: a prospective multicenter study
Jaap L J Hanssen1, Robert J P van der Wal2, Rachid Mahdad3
1Leiden University Center for Infectious Diseases (LU-CID), Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
Cotrimoxazole shows promise as an effective treatment for Gram-negative prosthetic joint infections (GN-PJI), offering an alternative to fluoroquinolones (FQs). Further research is needed to confirm its efficacy in GN-PJI management.
Area of Science:
- Orthopedics
- Infectious Diseases
- Pharmacology
Background:
- Gram-negative prosthetic joint infection (GN-PJI) is a serious complication.
- Fluoroquinolones (FQs) are the primary treatment but face rising resistance and side effects.
- Alternative antimicrobial strategies are crucial for effective GN-PJI management.
Purpose of the Study:
- To compare targeted antimicrobial strategies for GN-PJI.
- To evaluate treatments including oral fluoroquinolones (FQs), cotrimoxazole, and β-lactams.
- To review oral treatment options for GN-PJI.
Main Methods:
- Prospective, multicenter, registry-based study (2015-2020).
- Included patients with GN-PJI managed by debridement, antibiotics, and implant retention (DAIR) or one-stage revision (1SR).
- Survival analysis using Kaplan-Meier and Cox models.
Main Results:
- Seventy-four patients received FQ (64%), cotrimoxazole (18%), or β-lactams (18%).
- Failure-free survival did not significantly differ between FQ (72%) and cotrimoxazole (92%) groups.
- Cotrimoxazole demonstrated comparable outcomes to FQs in this cohort.
Conclusions:
- Cotrimoxazole is a potential effective targeted therapy for GN-PJI.
- This study suggests cotrimoxazole as a viable alternative to FQs.
- A randomized controlled trial is recommended to validate these findings.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Hand hygiene
Hand washing...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing

